Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in childrenHamtandi Magloire Natama, Angela M. Minassian, Edouard Ouédraogo et al.|The Lancet Infectious Diseases|2024Cited by 39
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled phase 2b trial in childrenHamtandi Magloire Natama, Angela M. Minassian, Jo Salkeld et al.|medRxiv|2024Cited by 1
A broadly-neutralizing antibody against <i>Ebolavirus</i> glycoprotein that potentiates the breadth and neutralization potency of other antibodiesFrancesca R. Donnellan, Simon J. Draper|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0